Figure S6 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer Article Swipe

PDF

Tianyu Qu , Lei Song , Jiali Xu , Xiyi Lu , Dandan Yin , Jiali Dai , Chen Zhang , Renhua Guo , Erbao Zhang ·

YOU? · · 2025 · Open Access · · DOI: https://doi.org/10.1158/0008-5472.29919042

METTL3-mediated post-transcriptional m6A modification contributes to the activation of MYLK-AS1 in TKI resistance of NSCLC.

Related Topics

Concepts

Glutamine Lung cancer Cancer research Resistance (ecology) Biology Internal medicine Medicine Genetics Ecology Amino acid

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1158/0008-5472.29919042
PDF: https://aacr.figshare.com/articles/journal_contribution/Figure_S6_from_MYLK-AS1_Enhances_Glutamine_Metabolism_to_Promote_EGFR_Inhibitor_Resistance_in_Non_Small_Cell_Lung_Cancer/29919042/1/files/57206889.pdf
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4413446152

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4413446152

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/0008-5472.29919042

Digital Object Identifier
Title: Figure S6 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2025

Year of publication
Publication date: 2025-08-15

Full publication date if available
Authors: Tianyu Qu, Lei Song, Jiali Xu, Xiyi Lu, Dandan Yin, Jiali Dai, Chen Zhang, Renhua Guo, Erbao Zhang

List of authors in order
Landing page: https://doi.org/10.1158/0008-5472.29919042

Publisher landing page
PDF URL: https://aacr.figshare.com/articles/journal_contribution/Figure_S6_from_MYLK-AS1_Enhances_Glutamine_Metabolism_to_Promote_EGFR_Inhibitor_Resistance_in_Non_Small_Cell_Lung_Cancer/29919042/1/files/57206889.pdf

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://aacr.figshare.com/articles/journal_contribution/Figure_S6_from_MYLK-AS1_Enhances_Glutamine_Metabolism_to_Promote_EGFR_Inhibitor_Resistance_in_Non_Small_Cell_Lung_Cancer/29919042/1/files/57206889.pdf

Direct OA link when available
Concepts: Glutamine, Lung cancer, Cancer research, Resistance (ecology), Biology, Internal medicine, Medicine, Genetics, Ecology, Amino acid

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4413446152
doi	https://doi.org/10.1158/0008-5472.29919042
ids.doi	https://doi.org/10.1158/0008-5472.29919042
ids.openalex	https://openalex.org/W4413446152
fwci	0.0
type	article
title	Figure S6 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T10631
topics[0].field.id	https://openalex.org/fields/13
topics[0].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[0].score	0.9905999898910522
topics[0].domain.id	https://openalex.org/domains/1
topics[0].domain.display_name	Life Sciences
topics[0].subfield.id	https://openalex.org/subfields/1306
topics[0].subfield.display_name	Cancer Research
topics[0].display_name	Cancer, Hypoxia, and Metabolism
topics[1].id	https://openalex.org/T12996
topics[1].field.id	https://openalex.org/fields/13
topics[1].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[1].score	0.942300021648407
topics[1].domain.id	https://openalex.org/domains/1
topics[1].domain.display_name	Life Sciences
topics[1].subfield.id	https://openalex.org/subfields/1305
topics[1].subfield.display_name	Biotechnology
topics[1].display_name	Cancer Research and Treatments
topics[2].id	https://openalex.org/T10417
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9376999735832214
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2740
topics[2].subfield.display_name	Pulmonary and Respiratory Medicine
topics[2].display_name	Lung Cancer Treatments and Mutations
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C2779349466
concepts[0].level	3
concepts[0].score	0.6649328470230103
concepts[0].wikidata	https://www.wikidata.org/wiki/Q181619
concepts[0].display_name	Glutamine
concepts[1].id	https://openalex.org/C2776256026
concepts[1].level	2
concepts[1].score	0.5526384711265564
concepts[1].wikidata	https://www.wikidata.org/wiki/Q47912
concepts[1].display_name	Lung cancer
concepts[2].id	https://openalex.org/C502942594
concepts[2].level	1
concepts[2].score	0.4500468373298645
concepts[2].wikidata	https://www.wikidata.org/wiki/Q3421914
concepts[2].display_name	Cancer research
concepts[3].id	https://openalex.org/C57473165
concepts[3].level	2
concepts[3].score	0.4191315174102783
concepts[3].wikidata	https://www.wikidata.org/wiki/Q7315604
concepts[3].display_name	Resistance (ecology)
concepts[4].id	https://openalex.org/C86803240
concepts[4].level	0
concepts[4].score	0.3348366618156433
concepts[4].wikidata	https://www.wikidata.org/wiki/Q420
concepts[4].display_name	Biology
concepts[5].id	https://openalex.org/C126322002
concepts[5].level	1
concepts[5].score	0.3099718689918518
concepts[5].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[5].display_name	Internal medicine
concepts[6].id	https://openalex.org/C71924100
concepts[6].level	0
concepts[6].score	0.3095511794090271
concepts[6].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[6].display_name	Medicine
concepts[7].id	https://openalex.org/C54355233
concepts[7].level	1
concepts[7].score	0.18173471093177795
concepts[7].wikidata	https://www.wikidata.org/wiki/Q7162
concepts[7].display_name	Genetics
concepts[8].id	https://openalex.org/C18903297
concepts[8].level	1
concepts[8].score	0.0
concepts[8].wikidata	https://www.wikidata.org/wiki/Q7150
concepts[8].display_name	Ecology
concepts[9].id	https://openalex.org/C515207424
concepts[9].level	2
concepts[9].score	0.0
concepts[9].wikidata	https://www.wikidata.org/wiki/Q8066
concepts[9].display_name	Amino acid
keywords[0].id	https://openalex.org/keywords/glutamine
keywords[0].score	0.6649328470230103
keywords[0].display_name	Glutamine
keywords[1].id	https://openalex.org/keywords/lung-cancer
keywords[1].score	0.5526384711265564
keywords[1].display_name	Lung cancer
keywords[2].id	https://openalex.org/keywords/cancer-research
keywords[2].score	0.4500468373298645
keywords[2].display_name	Cancer research
keywords[3].id	https://openalex.org/keywords/resistance
keywords[3].score	0.4191315174102783
keywords[3].display_name	Resistance (ecology)
keywords[4].id	https://openalex.org/keywords/biology
keywords[4].score	0.3348366618156433
keywords[4].display_name	Biology
keywords[5].id	https://openalex.org/keywords/internal-medicine
keywords[5].score	0.3099718689918518
keywords[5].display_name	Internal medicine
keywords[6].id	https://openalex.org/keywords/medicine
keywords[6].score	0.3095511794090271
keywords[6].display_name	Medicine
keywords[7].id	https://openalex.org/keywords/genetics
keywords[7].score	0.18173471093177795
keywords[7].display_name	Genetics
language	en
locations[0].id	doi:10.1158/0008-5472.29919042
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url	https://aacr.figshare.com/articles/journal_contribution/Figure_S6_from_MYLK-AS1_Enhances_Glutamine_Metabolism_to_Promote_EGFR_Inhibitor_Resistance_in_Non_Small_Cell_Lung_Cancer/29919042/1/files/57206889.pdf
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/0008-5472.29919042
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5023088457
authorships[0].author.orcid	https://orcid.org/0000-0002-4242-0615
authorships[0].author.display_name	Tianyu Qu
authorships[0].author_position	first
authorships[0].raw_author_name	Tianyu Qu
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5012950137
authorships[1].author.orcid
authorships[1].author.display_name	Lei Song
authorships[1].author_position	middle
authorships[1].raw_author_name	Lei Song
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5109678322
authorships[2].author.orcid	https://orcid.org/0009-0001-2645-7223
authorships[2].author.display_name	Jiali Xu
authorships[2].author_position	middle
authorships[2].raw_author_name	Jiali Xu
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5022554498
authorships[3].author.orcid
authorships[3].author.display_name	Xiyi Lu
authorships[3].author_position	middle
authorships[3].raw_author_name	Xiyi Lu
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5062985487
authorships[4].author.orcid	https://orcid.org/0000-0002-2550-5254
authorships[4].author.display_name	Dandan Yin
authorships[4].author_position	middle
authorships[4].raw_author_name	Dandan Yin
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5079313581
authorships[5].author.orcid	https://orcid.org/0000-0002-4533-9185
authorships[5].author.display_name	Jiali Dai
authorships[5].author_position	middle
authorships[5].raw_author_name	Jiali Dai
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5049412030
authorships[6].author.orcid
authorships[6].author.display_name	Chen Zhang
authorships[6].author_position	middle
authorships[6].raw_author_name	Chen Zhang
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5104275772
authorships[7].author.orcid
authorships[7].author.display_name	Renhua Guo
authorships[7].author_position	middle
authorships[7].raw_author_name	Renhua Guo
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5058207776
authorships[8].author.orcid	https://orcid.org/0000-0002-5752-7976
authorships[8].author.display_name	Erbao Zhang
authorships[8].author_position	last
authorships[8].raw_author_name	Erbao Zhang
authorships[8].is_corresponding	False
has_content.pdf	True
has_content.grobid_xml	True
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://aacr.figshare.com/articles/journal_contribution/Figure_S6_from_MYLK-AS1_Enhances_Glutamine_Metabolism_to_Promote_EGFR_Inhibitor_Resistance_in_Non_Small_Cell_Lung_Cancer/29919042/1/files/57206889.pdf
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Figure S6 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
has_fulltext	True
is_retracted	False
updated_date	2025-11-06T06:51:31.235846
primary_topic.id	https://openalex.org/T10631
primary_topic.field.id	https://openalex.org/fields/13
primary_topic.field.display_name	Biochemistry, Genetics and Molecular Biology
primary_topic.score	0.9905999898910522
primary_topic.domain.id	https://openalex.org/domains/1
primary_topic.domain.display_name	Life Sciences
primary_topic.subfield.id	https://openalex.org/subfields/1306
primary_topic.subfield.display_name	Cancer Research
primary_topic.display_name	Cancer, Hypoxia, and Metabolism
related_works	https://openalex.org/W2111784969, https://openalex.org/W2081780014, https://openalex.org/W2016733795, https://openalex.org/W2156682968, https://openalex.org/W4233695513, https://openalex.org/W2034845867, https://openalex.org/W2071106723, https://openalex.org/W2077950603, https://openalex.org/W3031069791, https://openalex.org/W4210501339
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.1158/0008-5472.29919042
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url	https://aacr.figshare.com/articles/journal_contribution/Figure_S6_from_MYLK-AS1_Enhances_Glutamine_Metabolism_to_Promote_EGFR_Inhibitor_Resistance_in_Non_Small_Cell_Lung_Cancer/29919042/1/files/57206889.pdf
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/0008-5472.29919042
primary_location.id	doi:10.1158/0008-5472.29919042
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url	https://aacr.figshare.com/articles/journal_contribution/Figure_S6_from_MYLK-AS1_Enhances_Glutamine_Metabolism_to_Promote_EGFR_Inhibitor_Resistance_in_Non_Small_Cell_Lung_Cancer/29919042/1/files/57206889.pdf
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/0008-5472.29919042
publication_date	2025-08-15
publication_year	2025
referenced_works_count	0
abstract_inverted_index.in	10
abstract_inverted_index.of	8, 13
abstract_inverted_index.to	5
abstract_inverted_index.TKI	11
abstract_inverted_index.m6A	2
abstract_inverted_index.the	6
abstract_inverted_index.MYLK-AS1	9
abstract_inverted_index.activation	7
abstract_inverted_index.resistance	12
abstract_inverted_index.contributes	4
abstract_inverted_index.modification	3
abstract_inverted_index.NSCLC.</p>	14
abstract_inverted_index.post-transcriptional	1
abstract_inverted_index.<p>METTL3-mediated	0
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	9
citation_normalized_percentile.value	0.45575404
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False